Table 2. Coverage calculated for each gene at r2>0.8 m.a.f.>0.1 before and after fine mapping.
Gene | Coverage after GAIN-MDD GWAS | Coverage with additional genotyping |
AFAP1L1 | 50% | 75% |
ANPEP | 68% | 93% |
FGF14 | 50% | 94% |
GZMK | 80% | 100% |
PCLO | 88% | 95% |
PTK2B | 83% | 98% |
ST3GAL6 | 80% | 93% |